123 related articles for article (PubMed ID: 35513187)
1. Microbiome Dynamics During Chemoradiation Therapy for Anal Cancer.
Lin D; El Alam MB; Jaoude JA; Kouzy R; Phan JL; Elnaggar JH; Resendiz B; Medrano AYD; Lynn EJ; Nguyen ND; Noticewala SS; Mathew GG; Holliday EB; Minsky BD; Das P; Morris VK; Eng C; Mezzari MP; Petrosino JF; Ajami NJ; Klopp AH; Taniguchi CM; Colbert LE
Int J Radiat Oncol Biol Phys; 2022 Aug; 113(5):974-984. PubMed ID: 35513187
[TBL] [Abstract][Full Text] [Related]
2. HPV-related anal cancer is associated with changes in the anorectal microbiome during cancer development.
Elnaggar JH; Huynh VO; Lin D; Hillman RT; Abana CO; El Alam MB; Tomasic KC; Karpinets TV; Kouzy R; Phan JL; Wargo J; Holliday EB; Das P; Mezzari MP; Ajami NJ; Lynn EJ; Minsky BD; Morris VK; Milbourne A; Messick CA; Klopp AH; Futreal PA; Taniguchi CM; Schmeler KM; Colbert LE
Front Immunol; 2023; 14():1051431. PubMed ID: 37063829
[TBL] [Abstract][Full Text] [Related]
3. Microbial Diversity and Composition Is Associated with Patient-Reported Toxicity during Chemoradiation Therapy for Cervical Cancer.
Mitra A; Grossman Biegert GW; Delgado AY; Karpinets TV; Solley TN; Mezzari MP; Yoshida-Court K; Petrosino JF; Mikkelson MD; Lin L; Eifel P; Zhang J; Ramondetta LM; Jhingran A; Sims TT; Schmeler K; Okhuysen P; Colbert LE; Klopp AH
Int J Radiat Oncol Biol Phys; 2020 May; 107(1):163-171. PubMed ID: 31987960
[TBL] [Abstract][Full Text] [Related]
4. RNA-seq analysis identifies transcriptomic profiles associated with anal cancer recurrence among people living with HIV.
Ye Y; Maroney KJ; Wiener HW; Mamaeva OA; Junkins AD; Burkholder GA; Sudenga SL; Khushman M; Al Diffalha S; Bansal A; Shrestha S
Ann Med; 2023 Dec; 55(1):2199366. PubMed ID: 37177979
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of the dynamic changes in gut microbiota in patients with extremely severe burns by 16S ribosomal RNA high-throughput sequencing technology].
Pan YY; Fan YF; Li JL; Cui SY; Huang N; Jin GY; Chen C; Zhang C
Zhonghua Shao Shang Za Zhi; 2020 Dec; 36(12):1159-1166. PubMed ID: 33379852
[No Abstract] [Full Text] [Related]
6. Comparative Survival of Patients With Anal Adenocarcinoma, Squamous Cell Carcinoma of the Anus, and Rectal Adenocarcinoma.
Franklin RA; Giri S; Valasareddy P; Lands LT; Martin MG
Clin Colorectal Cancer; 2016 Mar; 15(1):47-53. PubMed ID: 26362848
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers.
El Alam MB; Sims TT; Kouzy R; Biegert GWG; Jaoude JABI; Karpinets TV; Yoshida-Court K; Wu X; Delgado-Medrano AY; Mezzari MP; Ajami NJ; Solley T; Ahmed-Kaddar M; Lin LL; Ramondetta L; Jazaeri A; Jhingran A; Eifel PJ; Schmeler KM; Wargo J; Klopp AH; Colbert LE
PLoS One; 2021; 16(3):e0247905. PubMed ID: 33662003
[TBL] [Abstract][Full Text] [Related]
8. Primary surgery with or without postoperative radiotherapy in early stage squamous cell carcinoma in the anal canal and anal margin.
Leon O; Hagberg O; Johnsson A
Acta Oncol; 2018 Sep; 57(9):1209-1215. PubMed ID: 29490558
[TBL] [Abstract][Full Text] [Related]
9. Pencil Beam Scanning Proton Beam Chemoradiation Therapy With 5-Fluorouracil and Mitomycin-C for Definitive Treatment of Carcinoma of the Anal Canal: A Multi-institutional Pilot Feasibility Study.
Wo JY; Plastaras JP; Metz JM; Jiang W; Yeap BY; Drapek LC; Adams J; Baglini C; Ryan DP; Murphy JE; Parikh AR; Allen JN; Clark JW; Blaszkowsky LS; DeLaney TF; Ben-Josef E; Hong TS
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):90-95. PubMed ID: 31128146
[TBL] [Abstract][Full Text] [Related]
10. A Population-Based Cohort Analysis of Chemoradiation Versus Radiation Alone for Definitive Treatment of Stage I Anal Cancer in Older Patients.
Buckstein M; Arens Y; Wisnivesky J; Gaisa M; Goldstone S; Sigel K
Dis Colon Rectum; 2018 Jul; 61(7):787-794. PubMed ID: 29771796
[TBL] [Abstract][Full Text] [Related]
11. Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study).
Kim S; Jary M; André T; Vendrely V; Buecher B; François E; Bidard FC; Dumont S; Samalin E; Peiffert D; Pernot S; Baba-Hamed N; El Hajbi F; Bouché O; Desrame J; Parzy A; Zoubir M; Louvet C; Bachet JB; Nguyen T; Abdelghani MB; Smith D; De La Fouchardière C; Aparicio T; Bennouna J; Gornet JM; Jacquin M; Bonnetain F; Borg C
BMC Cancer; 2017 Aug; 17(1):574. PubMed ID: 28841909
[TBL] [Abstract][Full Text] [Related]
12. Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution.
Holliday EB; Morris VK; Johnson B; Eng C; Ludmir EB; Das P; Minsky BD; Taniguchi C; Smith GL; Koay EJ; Koong AC; Delclos ME; Skibber JM; Rodriguez-Bigas MA; You YN; Bednarski BK; Tillman MM; Chang GJ; Jennings K; Messick CA
Oncologist; 2022 Feb; 27(1):40-47. PubMed ID: 35305097
[TBL] [Abstract][Full Text] [Related]
13. Patient-Reported GI Outcomes in Patients With Anal Cancer Receiving Modern Chemoradiation.
Kouzy R; Abi Jaoude J; Lin D; El Alam MB; Minsky BD; Koay EJ; Das P; Holliday EB; Klopp AH; Colbert LE; Taniguchi CM
JCO Oncol Pract; 2020 Dec; 16(12):e1524-e1531. PubMed ID: 32609585
[TBL] [Abstract][Full Text] [Related]
14. Survival following salvage abdominoperineal resection for persistent and recurrent squamous cell carcinoma of the anus: do these disease categories affect survival?
Severino NP; Chadi SA; Rosen L; Coiro S; Choman E; Berho M; Wexner SD
Colorectal Dis; 2016 Oct; 18(10):959-966. PubMed ID: 26850085
[TBL] [Abstract][Full Text] [Related]
15. Hematologic Nadirs During Chemoradiation for Anal Cancer: Temporal Characterization and Dosimetric Predictors.
Lee AY; Golden DW; Bazan JG; Kopec M; Pelizzari CA; Aggarwal S; Chang DT; Liauw SL
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):306-312. PubMed ID: 28068238
[TBL] [Abstract][Full Text] [Related]
16. A Phase II Study of Capecitabine/Oxaliplatin With Concurrent Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Anal Canal.
Eng C; Jácome AA; Das P; Chang GJ; Rodriguez-Bigas M; Skibber JM; Wolff RA; Qiao W; Xing Y; Sethi S; Ohinata A; Crane CH
Clin Colorectal Cancer; 2019 Dec; 18(4):301-306. PubMed ID: 31350201
[TBL] [Abstract][Full Text] [Related]
17. Chemoradiation-Related Lymphopenia and Its Association with Survival in Patients with Squamous Cell Carcinoma of the Anal Canal.
Lee G; Kim DW; Muralidhar V; Mitra D; Horick NK; Eyler CE; Hong TS; Drapek LC; Allen JN; Blaszkowsky LS; Giantonio B; Parikh AR; Ryan DP; Clark JW; Wo JY
Oncologist; 2020 Dec; 25(12):1015-1022. PubMed ID: 32827337
[TBL] [Abstract][Full Text] [Related]
18. Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASE.
Gouriou C; Lemanski C; Pommier P; Le Malicot K; Saint A; Rivin Del Campo E; Evin C; Quero L; Regnault P; Baba-Hamed N; Ronchin P; Crehange G; Tougeron D; Menager-Tabourel E; Diaz O; Hummelsberger M; de la Rocherfordiere A; Drouet F; Vendrely V; Lièvre A
Br J Cancer; 2024 Mar; 130(5):769-776. PubMed ID: 38184691
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Toxicity and Treatment Outcomes in HIV-positive Versus HIV-negative Patients With Squamous Cell Carcinoma of the Anal Canal.
White EC; Khodayari B; Erickson KT; Lien WW; Hwang-Graziano J; Rao AR
Am J Clin Oncol; 2017 Aug; 40(4):386-392. PubMed ID: 25513996
[TBL] [Abstract][Full Text] [Related]
20. Cure Rates According to Dose-Intensity of Chemoradiation in T2N0 Squamous Cell Carcinoma of the Anal Canal.
Lustosa IKF; Camandaroba MPG; Mattos BRS; Silva SF; Iseas S; Riechelmann RP
Clin Colorectal Cancer; 2022 Sep; 21(3):e226-e231. PubMed ID: 35753955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
